Vanda Pharmaceuticals Inc (VNDA)
5.09
+0.15
(+3.04%)
USD |
NASDAQ |
Nov 22, 16:00
5.105
+0.02
(+0.29%)
After-Hours: 20:00
Vanda Pharmaceuticals Cash from Operations (Quarterly): -14.58M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -14.58M |
| June 30, 2024 | -6.928M |
| March 31, 2024 | 7.569M |
| December 31, 2023 | -3.732M |
| September 30, 2023 | -2.05M |
| June 30, 2023 | -13.22M |
| March 31, 2023 | 31.80M |
| December 31, 2022 | 9.416M |
| September 30, 2022 | 12.84M |
| June 30, 2022 | 5.685M |
| March 31, 2022 | 4.046M |
| December 31, 2021 | 26.61M |
| September 30, 2021 | 9.397M |
| June 30, 2021 | 19.02M |
| March 31, 2021 | 9.193M |
| December 31, 2020 | 19.30M |
| September 30, 2020 | 9.374M |
| June 30, 2020 | 24.01M |
| March 31, 2020 | -0.907M |
| December 31, 2019 | 9.791M |
| September 30, 2019 | 5.998M |
| June 30, 2019 | 20.52M |
| March 31, 2019 | 9.643M |
| December 31, 2018 | 15.26M |
| September 30, 2018 | 8.694M |
| Date | Value |
|---|---|
| June 30, 2018 | 4.391M |
| March 31, 2018 | 1.638M |
| December 31, 2017 | 3.466M |
| September 30, 2017 | 2.168M |
| June 30, 2017 | -2.26M |
| March 31, 2017 | -5.357M |
| December 31, 2016 | -1.183M |
| September 30, 2016 | 1.241M |
| June 30, 2016 | -3.262M |
| March 31, 2016 | -4.899M |
| December 31, 2015 | -0.356M |
| September 30, 2015 | -4.851M |
| June 30, 2015 | 12.10M |
| March 31, 2015 | 5.555M |
| December 31, 2014 | -13.39M |
| September 30, 2014 | -7.599M |
| June 30, 2014 | -36.66M |
| March 31, 2014 | -23.90M |
| December 31, 2013 | -12.15M |
| September 30, 2013 | -10.27M |
| June 30, 2013 | -8.043M |
| March 31, 2013 | -9.125M |
| December 31, 2012 | -13.85M |
| September 30, 2012 | -10.16M |
| June 30, 2012 | -12.21M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-14.58M
Minimum
Sep 2024
31.80M
Maximum
Mar 2023
7.831M
Average
9.284M
Median
Cash from Operations (Quarterly) Benchmarks
| Zevra Therapeutics Inc | -18.14M |
| Black Diamond Therapeutics Inc | -11.32M |
| Edgewise Therapeutics Inc | -27.37M |
| NovaBay Pharmaceuticals Inc | -2.061M |
| Palatin Technologies Inc | -7.016M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 12.06M |
| Free Cash Flow | -18.20M |
| Free Cash Flow Per Share (Quarterly) | -0.253 |
| Free Cash Flow to Equity (Quarterly) | -14.74M |
| Free Cash Flow to Firm (Quarterly) | -14.74M |
| Free Cash Flow Yield | -6.17% |